Literature DB >> 19786778

Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).

C Haense1, K Herholz, W J Jagust, W D Heiss.   

Abstract

AIM: We investigated the performance of FDG PET using an automated procedure for discrimination between Alzheimer's disease (AD) and controls, and studied the influence of demographic and technical factors.
METHODS: FDG PET data were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) [102 controls (76.0 +/- 4.9 years) and 89 AD patients (75.7 +/- 7.6 years, MMSE 23.5 +/- 2.1) and the Network for Standardisation of Dementia Diagnosis (NEST-DD) [36 controls (62.2 +/- 5.0 years) and 237 AD patients (70.8 +/- 8.3 years, MMSE 20.9 +/- 4.4). The procedure created t-maps of abnormal voxels. The sum of t-values in predefined areas that are typically affected by AD (AD t-sum) provided a measure of scan abnormality associated with a preset threshold for discrimination between patients and controls.
RESULTS: AD patients had much higher AD t-sum scores compared to controls (p < 0.01), which were significantly related to dementia severity (ADNI: r = -0.62, p < 0.01; NEST-DD: r = -0.59, p < 0.01). Early-onset AD patients had significantly higher AD t-sum scores than late-onset AD patients (p < 0.01). Differences between databases were mainly due to different age distributions. The predefined AD t-sum threshold yielded a sensitivity and specificity of 83 and 78% in ADNI and 78 and 94% in NEST-DD, respectively.
CONCLUSION: The automated FDG PET analysis procedure provided good discrimination power, and was most accurate for early-onset AD. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786778      PMCID: PMC7077083          DOI: 10.1159/000241879

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  36 in total

1.  Severity of vascular dementia is related to volume of metabolically impaired tissue.

Authors:  R Mielke; K Herholz; M Grond; J Kessler; W D Heiss
Journal:  Arch Neurol       Date:  1992-09

Review 2.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

3.  Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease.

Authors:  Christian Habeck; Norman L Foster; Robert Perneczky; Alexander Kurz; Panagiotis Alexopoulos; Robert A Koeppe; Alexander Drzezga; Yaakov Stern
Journal:  Neuroimage       Date:  2008-02-14       Impact factor: 6.556

4.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

Authors:  S Minoshima; B Giordani; S Berent; K A Frey; N L Foster; D E Kuhl
Journal:  Ann Neurol       Date:  1997-07       Impact factor: 10.422

5.  Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.

Authors:  Lisa Mosconi; Wai H Tsui; Karl Herholz; Alberto Pupi; Alexander Drzezga; Giovanni Lucignani; Eric M Reiman; Vjera Holthoff; Elke Kalbe; Sandro Sorbi; Janine Diehl-Schmid; Robert Perneczky; Francesca Clerici; Richard Caselli; Bettina Beuthien-Baumann; Alexander Kurz; Satoshi Minoshima; Mony J de Leon
Journal:  J Nucl Med       Date:  2008-02-20       Impact factor: 10.057

6.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.

Authors:  C DeCarli; D G Murphy; M Tranh; C L Grady; J V Haxby; J A Gillette; J A Salerno; A Gonzales-Aviles; B Horwitz; S I Rapoport
Journal:  Neurology       Date:  1995-11       Impact factor: 9.910

7.  Age, neuropathology, and dementia.

Authors:  George M Savva; Stephen B Wharton; Paul G Ince; Gillian Forster; Fiona E Matthews; Carol Brayne
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

8.  Cortical abnormalities in Alzheimer's disease.

Authors:  N L Foster; T N Chase; L Mansi; R Brooks; P Fedio; N J Patronas; G Di Chiro
Journal:  Ann Neurol       Date:  1984-12       Impact factor: 10.422

9.  Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.

Authors:  Kazunari Ishii; Atsushi K Kono; Hiroki Sasaki; Naokazu Miyamoto; Tetsuya Fukuda; Setsu Sakamoto; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-10       Impact factor: 9.236

Review 10.  PET studies in dementia.

Authors:  Karl Herholz
Journal:  Ann Nucl Med       Date:  2003-04       Impact factor: 2.668

View more
  32 in total

Review 1.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 3.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

Review 4.  FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough?

Authors:  Giovanni Lucignani; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

5.  Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.

Authors:  Anna Caroli; Annapaola Prestia; Kewei Chen; Napatkamon Ayutyanont; Susan M Landau; Cindee M Madison; Cathleen Haense; Karl Herholz; Flavio Nobili; Eric M Reiman; William J Jagust; Giovanni B Frisoni
Journal:  J Nucl Med       Date:  2012-02-17       Impact factor: 10.057

Review 6.  Neuroimaging of dementia in 2013: what radiologists need to know.

Authors:  Sven Haller; Valentina Garibotto; Enikö Kövari; Constantin Bouras; Aikaterini Xekardaki; Cristelle Rodriguez; Maciej Jakub Lazarczyk; Panteleimon Giannakopoulos; Karl-Olof Lovblad
Journal:  Eur Radiol       Date:  2013-07-10       Impact factor: 5.315

7.  Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2013-08       Impact factor: 18.302

Review 8.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

9.  Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease.

Authors:  Katherine R Gray; Robin Wolz; Rolf A Heckemann; Paul Aljabar; Alexander Hammers; Daniel Rueckert
Journal:  Neuroimage       Date:  2012-01-06       Impact factor: 6.556

Review 10.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.